Colombia vs Latvia: Reported rate of new cervical cancer cases
Colombia
13.01 per 100,000 women
in 2017
Latvia
13.3 per 100,000 women
in 2017
Colombia rank
8th
Latvia rank
7th
Reported rate of new cervical cancer cases over time
- Colombia
- Latvia
How they compare
Latvia currently reports 13.3 per 100,000 women against 13.01 per 100,000 women in Colombia, a difference of 0.29 per 100,000 women.
The two have swapped places 1 time across 15 shared years of data; in 2003 it was Colombia ahead.
Colombia ranks 8th and Latvia ranks 7th of 46 countries.
Across the 2 decades both report, Colombia averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Colombia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.18 per 100,000 women | 12.31 per 100,000 women | 6.87 per 100,000 women | Colombia |
| 2010s | 13.87 per 100,000 women | 15.91 per 100,000 women | 2.04 per 100,000 women | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Colombia or Latvia?
- Latvia, at 13.3 per 100,000 women against 13.01 per 100,000 women in Colombia as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Colombia and Latvia?
- 0.29 per 100,000 women, with Latvia ahead.
- How many years of comparable data are there for Colombia and Latvia?
- 15 years are reported by both, from 2003 to 2017.
- How do Colombia and Latvia rank globally for reported rate of new cervical cancer cases?
- Colombia ranks 8th and Latvia ranks 7th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.